Back to everyone

Nick Dixon‑Clegg

Partner, Head of Independent Investments

Nick Dixon-Clegg

Nick joined Oxford Science Enterprises in July 2020, bringing over a decade of investment and corporate finance experience.

Nick leads the Independent Investments Team, working exclusively with established portfolio companies that have developed a significant degree of independence from OSE. He manages OSE’s investments in these companies, supports their continued growth and development, and is responsible for investing fresh OSE capital into them.

Prior to OSE, Nick was an Investment Principal at Valiance, a MedTech-focused venture capital firm. He has also held roles as a private equity investor at Nordic Capital and as an investment banker at Bank of America Merrill Lynch.

Nick holds a Triple First Class MA (Cantab) in Natural Sciences from the University of Cambridge.

Nick sits on the board of

  • Bibliu
  • Circadian Therapeutics
  • Dark Blue Therapeutics
  • EnzBond
  • Natcap
  • NavLive
  • PrOXisense
  • Realized care

Nick is an observer on the board of

  • Genomics
  • HEXR
  • Scenic Biotech
  • Theolytics

Meet all our


Alex Hammacher
Alex HammacherHead of Strategic Operations & Corporate Finance
Athene Blakeman
Athene BlakemanHead of Legal
Claire LaRocca
Claire LaRoccaHead of Communications
Emily Matthews
Emily MatthewsResponsible Investment & ESG Manager
Jim Wilkinson
Jim WilkinsonChief Financial Officer
Jon Wall
Jon WallPortfolio Tech Talent Lead
Lilly Bussmann
Lilly BussmannHead of Strategic Capital
Lisa Bedwell
Lisa BedwellHead of Marketing
Matthew Myers
Matthew MyersAssociate, Independent Investments
Oliver Mahony
Oliver MahonyPrincipal, Independent Investments
Pete Wilder
Pete WilderHead of Property
Polly Elvin
Polly ElvinHead of Investor Relations & Co-Investors
Sarah Shackelton
Sarah ShackeltonChief Talent Officer
Sive Ozer
Sive OzerSenior Legal Counsel
Wallace Wallace
Wallace WallaceAssociate, Independent Investments